Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Emergence Delirium
Interventions
DRUG

Dexmedetomidine

Intervention group will receive Total Intravenous Dexmedetomidine as their anesthetic maintenance agent. Intravenous Dexmedetomidine 1.5ug/kg will be administered within 10 minutes and maintenance dose of 1.5ug/kg/hour continued as the sole anesthetic maintenance agent, thereafter.

DRUG

Sevoflurane

Inhalation Sevoflurane will be administered as an anesthetic maintenance agent. Sevoflurane at 2 - 3 Vol% will be administered throughout the operative procedure.

Trial Locations (1)

15811

Pelita Harapan University, Tangerang

All Listed Sponsors
lead

Pelita Harapan University

OTHER

NCT06482125 - Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia | Biotech Hunter | Biotech Hunter